Not Yet Recruiting Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse NCT07437963 Conditions Ganglioneuroblastoma, Neoplasms, Neoplasms by Histologic Type, +12 more Locations Not specified View Trial Details
